Multicenter Registry of Atrial Fibrillation Ablation With Radiofrequency Balloon Catheter

Recruiting now

Conditions studied: Atrial Fibrillation

In brief

All consecutive patients with paroxysmal or persistent atrial fibrillation undergoing pulmonary vein isolation with the radiofrequency balloon catheter (RFB) "Heliostar" (Biosense Webster) will be included in a multicenter observational registry. The aim of the study is to assess the safety and arrhythmic outcome of atrial fibrillation ablation with the RFB in a real-world setting.

Key facts

Study ID

NCT06333327

Run by

Universitair Ziekenhuis Brussel

People needed

2000

Starts

2021-01-01

Expected to finish

2030-12-01

Last updated by the study team

2024-03-27

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• symptomatic atrial fibrillation with indication to catheter ablation

You may not qualify if…

• age <18 years old
• pregnancy
• any contraindications to catheter ablation

Where it is running

• UZ Brussel Heart Rhythm Management Center — Brussels, Belgium (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.